Clinical Trial Update: A Clinical Study of Hetrombopag Olamine Tablets for Thrombocytopenia Induced by Anti-tumor Treatment in Advanced Breast Cancer [Phase 2]

View source ↗

Summary

A completed Phase 2 study evaluating hetrombopag olamine tablets for thrombocytopenia induced by anti-tumor therapy in patients with advanced breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Hetrombopag Olamine Tablets (hetrombopag olamine)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED